Skip to content
Intrommune Therapeutics
  • About Us
  • Our Science
    • Overview
    • Peanut INT301
  • News & Resources
  • Blog
  • Contact
Intrommune Therapeutics

Kelley Nelson

Intrommune Expands and Strengthens Senior Leadership Team

Leave a Comment / Press Releases / By Kelley Nelson

Intrommune Therapeutics Names Nandini Murthy as Head of Regulatory

Leave a Comment / Press Releases / By Kelley Nelson

Intrommune Announces Expanded Scope of Phase 1 OMEGA Study in Adults with Peanut Allergy

Leave a Comment / Press Releases / By Kelley Nelson

This Startup is Creating a Toothpaste for Your Peanut Allergy 

Leave a Comment / In the News / By Kelley Nelson

The time is now for a desensitization method that is safe, effective and easy to use. This is exactly the solution that Intrommune Therapeutics offers.

Tonya Winders

President, CEO
Allergy & Asthma Network

Learn More
  • About Us
  • Our Science
    • Overview
    • Peanut INT301
  • News & Resources
  • Blog
  • Contact
  • About Us
  • Our Science
  • Peanut INT301
  • News & Resources
  • Contact

Sign up for Intrommune's newsletter and stay informed of company developments.


Intrommune
  • About Us
  • Our Science
  • Peanut INT301
  • News & Resources
  • Contact

Sign up for Intrommune's newsletter and stay informed of company developments.


Copyright © 2023 Intrommune Therapeutics | Privacy Policy | Accessibility Statement